Connect with us

Hi, what are you looking for?

Alive Business PlanAlive Business Plan

Investing

Peloton no longer faces bankruptcy but PTON shares remain unattractive

Peloton Interactive Inc (NASDAQ: PTON) has secured financing and cut costs over the past year or so to dilute concerns of bankruptcy, but its stock remains far from worth owning in 2025.

While PTON remains in loss on a GAAP basis, the aforementioned efforts helped the connected fitness company generate $70.3 million in adjusted EBITDA in its fiscal 2025.

At the time of writing, Peloton stock is down about 40% versus its year-to-date high.

Why Peloton stock remains unattractive to own

While the exercise equipment company no longer faces an imminent risk of bankruptcy, Peloton shares’ long-term investment appeal remains weak.

PTON now needs sustainable means of sales growth to trigger a meaningful recovery in its stock price, since the management may soon run out of costs to cut.

This could again lead to distress on the bottom line if sales don’t rebound – signs of which have not been evident in the company’s recent quarterly reports.

Revenue continues to shrink at Peloton with no clear end in sight.

Additionally, the Nasdaq-listed firm still has just under $1.0 billion in long-term net debt that limits its ability to invest in growth initiatives.

In short, PTON stock remains a high-risk investment for the back half of 2025 because any misstep could reignite losses and put pressure back on the company’s balance sheet.

CFO Elizabeth Coddington recently sold PTON shares

Peloton stock is even more unattractive to own following news that Elizabeth F. Coddington, its chief of finance, has recently trimmed her exposure to the connected fitness company.

On June 16th, Coddington sold a little under 39,000 PTON shares for about $269,000 in total.

While the company’s chief financial officer still owns nearly 300,000 shares of Peloton, an 11.62% decrease in her stake this week, nonetheless, reflects waning confidence in the company’s future.  

Peloton stock may currently be trading at a fraction of its peak price during the COVID pandemic, but it’s not necessarily a cheap stock to own.

With no clear growth catalyst and a real risk of future financial strain, investors may be better off sitting on the sidelines for now on this one.

Wall Street remains bullish on Peloton Interactive Inc

Despite ongoing challenges, analysts seem to be fixating more on cost cuts and adjusted EBITDA that Peloton Interactive has been able to achieve so far.

This is evidenced in Wall Street’s consensus rating on PTON that remains at “overweight” with an average price target of a tad below $9.0, which indicates potential upside of more than 40% from current levels.

In fact, the Street-high target on Peloton stock currently sits at a whopping $20, signalling potential for a more than 200% rally from here. That said, the exercise equipment company doesn’t pay a dividend at writing.

The post Peloton no longer faces bankruptcy but PTON shares remain unattractive appeared first on Invezz

Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    You May Also Like

    Stock

    (TheNewswire) As global demand for rare earth magnets accelerates—driven by electric vehicles, renewable energy systems, and high-performance computing—the need for secure, domestic sources of...

    Economy

    Bitcoin Rebounds to $83,404 on April 11, 2025 Amid Renewed Investor Confidence On April 11, 2025, Bitcoin (BTC-USD) demonstrated a significant rebound, opening at...

    Stock

    Radiopharm Theranostics (ASX:RAD, ‘Radiopharm’ or the ‘Company’), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need,...

    Editor's Pick

    The post 36Crypto: Crypto Journalism with Realtime News and Insightful Analysis appeared first on Coinpedia Fintech News In an era where digital finance continues...



    Disclaimer: alivebusinessplan.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 alivebusinessplan.com